Pharvaris Netherlands B.v.
Clinical trials sponsored by Pharvaris Netherlands B.v., explained in plain language.
-
New daily pill could stop painful swelling attacks for HAE patients
Disease control OngoingThis Phase 3 trial tests whether a once-daily pill called deucrictibant can prevent sudden swelling attacks in people aged 12 and older with hereditary angioedema (HAE). Participants receive either the drug or a placebo for 24 weeks, and researchers count how many attacks occur. …
Phase: PHASE3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New pill could stop dangerous swelling attacks in hereditary angioedema
Symptom relief ENROLLING_BY_INVITATIONThis study tests a pill called deucrictibant for quickly treating swelling attacks in people with hereditary angioedema (HAE), including life-threatening throat swelling. About 150 adults who have had HAE attacks before will take the drug as needed and be monitored for safety and…
Phase: PHASE2, PHASE3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC